companies making glp-1 drugs Receptor Agonist Market Size & Analysis, 2026-2033 The Biggest Winner of GLP-1
Description
The most widely used is Tirzepatide, as it helps you shed a considerable amount of weight, followed by Semaglutide and Liraglutide
doi:10.1016/S0140-6736(05)61032-X Lu X, Xie Q, Pan X, et al
All of the dynamics around GLP-1s, compounding shortage workarounds, and potential for DTC telehealth fallout I described last August seem to be playing out in 2025
Macronutrient blends expanded at a 14.1% CAGR through 2030
As research continues, long-term safety data across broader populations are still emerging
Helvaci N, Yildiz BO (2023) Current and emerging drug treatment strategies for polycystic ovary syndrome
